For help on how to get the results you want, see our search tips.
94 results
Categories
Human Remove Human filter
-
List item
Summary of opinion: Translarna (updated)
ataluren, opinion date: 27/06/2019, Negative, Last updated: 18/10/2019 -
List item
Summary of opinion: Revolade (updated)
eltrombopag, opinion date: 17/10/2019, Negative, Last updated: 18/10/2019 -
List item
Summary of opinion: Symkevi
tezacaftor / ivacaftor, opinion date: 26/07/2018, Positive, Last updated: 27/07/2018 -
List item
Summary of opinion: Adcetris
brentuximab vedotin, opinion date: 13/12/2018, Positive, Last updated: 14/12/2018 -
List item
Summary of opinion: Mozobil
plerixafor, opinion date: 28/03/2019, Positive, Last updated: 29/03/2019 -
List item
Summary of opinion: Bortezomib Fresenius Kabi
bortezomib, opinion date: 19/09/2019, Positive, Last updated: 20/09/2019 -
List item
Summary of opinion: Ivozall
clofarabine, opinion date: 19/09/2019, Positive, Last updated: 20/09/2019 -
List item
Summary of opinion: Arsenic trioxide Accord
arsenic trioxide, opinion date: 19/09/2019, Positive, Last updated: 20/09/2019 -
List item
Summary of opinion: Darzalex
daratumumab, opinion date: 17/10/2019, Positive, Last updated: 18/10/2019 -
List item
Summary of opinion: Soliris
eculizumab, opinion date: 25/07/2019, Positive, Last updated: 26/07/2019 -
List item
Summary of opinion: Imbruvica
ibrutinib, opinion date: 28/06/2019, Positive, Last updated: 28/06/2019 -
List item
Summary of opinion: Kalydeco
ivacaftor, opinion date: 17/10/2019, Positive, Last updated: 18/10/2019 -
List item
Summary of opinion: Clopidogrel / Acetylsalicylic acid Mylan
clopidogrel / acetylsalicylic acid, opinion date: 14/11/2019, Positive, Last updated: 15/11/2019 -
List item
Summary of opinion: Deferasirox Accord
deferasirox, opinion date: 14/11/2019, Positive, Last updated: 15/11/2019 -
List item
Summary of opinion: Revlimid
lenalidomide, opinion date: 14/11/2019, Positive, Last updated: 15/11/2019 -
List item
Opinion/decision on a Paediatric investigation plan (PIP): Ninlaro, Ixazomib (updated)
Decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Oncology, PIP number: EMEA-001410-PIP02-17-M02, decision date: 16/07/2019, Last updated: 14/11/2019, compliance check: X -
List item
Opinion/decision on a Paediatric investigation plan (PIP): Soliris, Eculizumab (updated)
Decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Neurology, PIP number: EMEA-000876-PIP03-14-M03, decision date: 16/07/2019, Last updated: 14/11/2019, compliance check: X -
List item
Opinion/decision on a Paediatric investigation plan (PIP): NexoBrid, Concentrate of proteolytic enzymes in bromelain (updated)
Decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Other, PIP number: EMEA-000142-PIP02-09-M08, decision date: 16/07/2019, Last updated: 13/11/2019, compliance check: X -
List item
Opinion/decision on a Paediatric investigation plan (PIP): Darzalex, Daratumumab (updated)
Decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Oncology, PIP number: EMEA-002152-PIP02-17-M01, decision date: 12/06/2019, Last updated: 08/11/2019, compliance check: X -
List item
Opinion/decision on a Paediatric investigation plan (PIP): Imbruvica, Ibrutinib (updated)
Decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Oncology, PIP number: EMEA-001397-PIP03-14-M04, decision date: 12/06/2019, Last updated: 08/11/2019, compliance check: X -
List item
Opinion/decision on a Paediatric investigation plan (PIP): Ocaliva, Obeticholic acid (updated)
Decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Gastroentology-Hepatology, PIP number: EMEA-001304-PIP02-13-M04, decision date: 12/06/2019, Last updated: 08/11/2019, compliance check: X -
List item
Opinion/decision on a Paediatric investigation plan (PIP): Strensiq, asfotase alfa (updated)
Decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Endocrinology, -gynacology-fertility-metabolism, PIP number: EMEA-000987-PIP01-10-M04, decision date: 15/05/2019, Last updated: 30/10/2019, compliance check: X -
List item
Opinion/decision on a Paediatric investigation plan (PIP): Natpar, Recombinant parathyroid hormone
Decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Endocrinology, -gynacology-fertility-metabolism, PIP number: EMEA-001526-PIP01-13-M03, decision date: 17/04/2019, Last updated: 24/06/2019, compliance check: X -
List item
Opinion/decision on a Paediatric investigation plan (PIP): Lartruvo, Olaratumab
Decision type: W: decision granting a waiver in all age groups for all conditions/indications, therapeutic area: Oncology, PIP number: EMEA-001760-PIP01-15-M03, decision date: 22/03/2019, Last updated: 24/06/2019, compliance check: X -
List item
Opinion/decision on a Paediatric investigation plan (PIP): Cresemba, Isavuconazonium (sulfate)
Decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infectious diseases, PIP number: EMEA-001301-PIP02-12-M03, decision date: 22/03/2019, Last updated: 24/06/2019, compliance check: X